Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Naltrexone for East Asians
NCT02026011Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Dec 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of naltrexone in alcohol use disorder (AUD), sponsored by University of California, Los Angeles. Primary endpoints: Subjective Response - Craving for Alcohol at 1.5 hours and Subjective Response - Stimulation at 1.5 hours. Started Dec 2013; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02026011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02026011.